Compare Bristol-Myers Squibb Co (BMY) vs MINISO Group Holding Ltd (MNSO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs MINISO Group Holding Ltd — how do they compare? Bristol-Myers Squibb Co trades at $63.63 (market cap $129.94B), while MINISO Group Holding Ltd trades at $11.97 (market cap $3.62B). The key difference: Bristol-Myers Squibb Co is far larger — about 35.9× MINISO Group Holding Ltd's market cap, and MINISO Group Holding Ltd pays the higher dividend (5.53%). Which is the better fit depends on your goals.
| BMY | MNSO | |
|---|---|---|
Market Cap | $129.94B | $3.62B |
Sector | Health | Technology |
52-Week High | $65.89 | $26.63 |
52-Week Low | $42.60 | $11.30 |
Enterprise Value | $163.92B | $4.29B |
Dividend Yield | 3.96% | 5.53% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About MINISO Group Holding Ltd
MINISO Group Holding Ltd is a global lifestyle product retailer known for its aesthetically pleasing, high-quality, and low-cost goods. The company operates a network of branded stores worldwide, offering a diverse range of merchandise, including household goods, cosmetics, toys, and digital accessories. MINISO's business model emphasizes rapid product iteration, efficient supply chain management, and a joint venture and franchise partner network to facilitate its global expansion.
Read more on MNSO →
